🌱 KidneyEnergy.com

← brief for 2026-11-04 · Slowing decline

Eneboparatide induces prolonged 24-hour PTH 1 receptor activation.

Article D Peer reviewed Preclinical

Key takeaways

This study looked at a drug called eneboparatide in cells and animals. It found the drug keeps a specific receptor active for a long time. This helps control calcium levels in people with a rare hormone condition. The work was not done in people yet.

Who did this work

Gaume X · Ravel G · Berardet C · Aouadi M

Source

Article · PubMed, Nutritional supplements and CKD · 2026 Sep 21
https://pubmed.ncbi.nlm.nih.gov/42978850/